New York: Researchers have found that two new gene-based blood tests can reliably detect previously unidentifiable forms of one of the most aggressive forms of skin cancer.
Having quick and accurate monitoring tools for all types of metastatic melanoma, the medical term for the disease, may make it easier for physicians to detect early signs of cancer recurrence, the researchers said.
The new blood tests, which take only 48 hours, are currently only available for research purposes.
"Our goal is to use these tests to make more informed treatment decisions and, specifically, to identify as early as possible when a treatment has stopped working, cancer growth has resumed, and the patient needs to switch therapy," said senior study investigator and dermatologist David Polsky, Professor at NYU Langone Medical Center in New York.
The new tools are the first to identify melanoma DNA in the blood of patients whose cancer is spreading and who lack defects in either the BRAF or NRAS genes, already known to drive cancer growth, the study authors said.
The new tests monitor blood levels of DNA fragments, known as circulating tumour DNA (ctDNA), that are released into the blood when tumour cells die and break apart, said Polsky who presented his team's latest findings at the annual meeting of the American Association for Cancer Research in Washington, DC.
Specifically, the tests detect evidence of changes in the chemical building blocks (or mutations) of a gene that controls telomerase reverse transcriptase (TERT), a protein that helps cancer cells maintain the physical structure of their chromosomes.
The blood tests, developed in conjunction with Bio-Rad Laboratories in Hercules, California, may have advantages over current methods for monitoring the disease because the tests avoid the radiation exposure that comes with CT scans, and the tests can be performed more easily and more often, Polsky said.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Having quick and accurate monitoring tools for all types of metastatic melanoma, the medical term for the disease, may make it easier for physicians to detect early signs of cancer recurrence, the researchers said.
The new blood tests, which take only 48 hours, are currently only available for research purposes.
The new tools are the first to identify melanoma DNA in the blood of patients whose cancer is spreading and who lack defects in either the BRAF or NRAS genes, already known to drive cancer growth, the study authors said.
Advertisement
Specifically, the tests detect evidence of changes in the chemical building blocks (or mutations) of a gene that controls telomerase reverse transcriptase (TERT), a protein that helps cancer cells maintain the physical structure of their chromosomes.
Advertisement
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
COMMENTS
Advertisement
Blood Tests Can Predict Parkinson's 7 Years Before Symptoms: Study Blood Test Can Detect Rare Forms Of Dementia, Neurological Diseases: Study Kevin Jonas Shares Skin Cancer Diagnosis: "I Have To Get A Surgery" Over 300 Indian Students Return As Quota Row Sparks Violence In Bangladesh "Jindal Group Executive Showed Porn, Groped Me On Flight": Woman To NDTV Full Recovery From Global IT Outage Could Take Time: 10 Points CrowdStrike: All About The Cybersecurity Giant Behind Global IT Outage UP Government Forms Lucknow-SCR On The Lines Of Delhi-NCR The Situation At Delhi, Mumbai Airports Day After Global IT Outage Track Latest News Live on NDTV.com and get news updates from India and around the world.